REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Clinical trial NCT03185013 · COMPLETED

Trial details

NCT number: NCT03185013
Sponsor: Inovio Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Dysplasia Cervical High Grade Squamous Intraepithelial Lesion HSIL

Start date: 2017-06-28
Primary completion: 2020-07-08
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.